Exeter Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$908K Sell
11,607
-82
-0.7% -$6.62K 0.35% 62
2026
Q1
$1.01M Buy
11,689
+1,446
+14% +$139K 0.41% 59
2025
Q4
$984K Buy
10,243
+1,238
+14% +$120K 0.42% 59
2025
Q3
$858K Buy
9,005
+82
+0.9% +$7.54K 0.37% 64
2025
Q2
$778K Sell
8,923
-1,261
-12% -$107K 0.35% 65
2025
Q1
$915K Buy
10,184
+285
+3% +$25.5K 0.41% 64
2024
Q4
$791K Buy
9,899
+42
+0.4% +$3.64K 0.36% 64
2024
Q3
$887K Buy
9,857
+186
+2% +$15.6K 0.39% 65
2024
Q2
$761K Buy
9,671
+280
+3% +$23K 0.36% 65
2024
Q1
$788K Buy
9,391
+2,222
+31% +$190K 0.36% 66
2023
Q4
$621K Sell
7,169
-2,583
-26% -$197K 0.3% 66
2023
Q3
$764K Buy
9,752
+580
+6% +$48.6K 0.4% 65
2023
Q2
$801K Sell
9,172
-3,783
-29% -$326K 0.41% 66
2023
Q1
$1.04M Buy
12,955
+3,392
+35% +$276K 0.52% 61
2022
Q4
$743K Sell
9,563
-4,498
-32% -$365K 0.39% 61
2022
Q3
$1.14M Sell
14,061
-115
-0.8% -$10.3K 0.66% 56
2022
Q2
$1.27M Buy
14,176
+331
+2% +$33.5K 0.71% 54
2022
Q1
$1.54M Sell
13,845
-205
-1% -$21.7K 0.83% 46
2021
Q4
$1.48M Sell
14,050
-231
-2% -$26.7K 0.81% 47
2021
Q3
$1.79M Buy
14,281
+216
+2% +$28K 1.07% 37
2021
Q2
$1.78M Buy
14,065
+657
+5% +$82.5K 1.03% 37
2021
Q1
$1.58M Buy
13,408
+342
+3% +$40.1K 1% 39
2020
Q4
$1.53M Buy
13,066
+1,133
+9% +$125K 1.06% 39
2020
Q3
$1.24M Buy
11,933
+40
+0.3% +$4.02K 0.97% 39
2020
Q2
$1.09M Sell
11,893
-17
-0.1% -$1.63K 0.91% 43
2020
Q1
$1.07M Sell
11,910
-300
-2% -$31.9K 1.01% 41
2019
Q4
$1.39M Sell
12,210
-600
-5% -$65.8K 1.07% 41
2019
Q3
$1.39M Buy
12,810
+82
+0.6% +$8.55K 1.11% 39
2019
Q2
$1.24M Sell
12,728
-69
-0.5% -$6.3K 1.04% 42
2019
Q1
$1.17M Buy
12,797
+59
+0.5% +$5.28K 1.01% 42
2018
Q4
$1.16M Hold
12,738
1.09% 40
2018
Q3
$1.25M Sell
12,738
-86
-0.7% -$7.95K 1.03% 42
2018
Q2
$1.1M Sell
12,824
-377
-3% -$31.5K 0.97% 43
2018
Q1
$1.06M Buy
13,201
+2,231
+20% +$184K 0.91% 45
2017
Q4
$886K Buy
+10,970
New +$879K 0.77% 50

Other funds holding MDT

Exeter Financial's MDT Position: Q2 2026 in Review

Exeter Financial reduced its Medtronic (MDT) stake by 0.7% in Q2 2026, selling an estimated $6.62K and leaving 11,607 shares worth $908K. The position accounts for 0.35% of the portfolio, ranked #62.

Exeter Financial first reported a position in MDT in Q4 2017 and has held it in 35 quarters since. The position peaked at $1.79M in Q3 2021. 823 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Exeter Financial held 11,607 shares of Medtronic worth $908K as of Q2 2026.
  • Exeter Financial sold 82 Medtronic shares in Q2 2026, an estimated $6.62K.
  • Medtronic made up 0.35% of Exeter Financial's portfolio in Q2 2026, its #62 holding.
  • Exeter Financial first reported a position in Medtronic in Q4 2017 and has held it in 35 quarters since.
  • Exeter Financial's Medtronic position peaked at $1.79M in Q3 2021.
  • 823 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Exeter Financial's 13F filing for Q2 2026, filed 16 Jul 2026.